Pollard Banknote Limited (TSE:PBL – Get Free Report)’s share price passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of C$19.70 and traded as high as C$22.63. Pollard Banknote shares last traded at C$22.30, with a volume of 24,214 shares trading hands.
Analyst Upgrades and Downgrades
A number of research firms recently weighed in on PBL. Cormark decreased their target price on shares of Pollard Banknote from C$42.00 to C$37.00 in a research report on Thursday, March 27th. Raymond James cut their target price on shares of Pollard Banknote from C$46.00 to C$39.00 and set an “outperform” rating for the company in a research note on Tuesday, March 11th.
Read Our Latest Research Report on Pollard Banknote
Pollard Banknote Stock Up 0.5%
Pollard Banknote Announces Dividend
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 15th were paid a $0.05 dividend. This represents a $0.20 annualized dividend and a yield of 0.90%. The ex-dividend date of this dividend was Monday, March 31st. Pollard Banknote’s dividend payout ratio (DPR) is 11.47%.
Pollard Banknote Company Profile
Pollard Banknote Ltd is principally engaged in the manufacturing, development, and sale of lottery and charitable gaming products throughout the world. Its operating segments are Lotteries and charitable gaming and eGaming systems. It provides instant tickets and lottery services including licensed products, distribution, SureTrack lottery management system, retail telephone selling, marketing, iLottery, digital products, Social InstantsTM, retail management services, and instant ticket vending machines.
Featured Articles
- Five stocks we like better than Pollard Banknote
- Are Penny Stocks a Good Fit for Your Portfolio?
- Ignore the Noise—Samsara Stock Is Still a Strong Buy
- How to Short a Stock in 5 Easy Steps
- 3 Stocks Set to Double—And There’s Still Time to Buy
- How Can Investors Benefit From After-Hours Trading
- Analysts Can’t Get Enough of These Little-Known Biopharma Stocks
Receive News & Ratings for Pollard Banknote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pollard Banknote and related companies with MarketBeat.com's FREE daily email newsletter.